Mercer, Louise K <br/><br/>
Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population.  [electronic resource] 

 -  Rheumatology (Oxford, England)  Jan 2013 
 - 91-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1462-0332 
<br/><br/><label>Standard No.: </label>10.1093/rheumatology/kes350  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antirheumatic Agents--adverse effects<br/>Arthritis, Rheumatoid--drug therapy<br/>Female<br/>Humans<br/>Incidence<br/>Male<br/>Middle Aged<br/>Neoplasms--epidemiology<br/>Registries<br/>Risk<br/>United Kingdom--epidemiology